| Product Code: ETC10402217 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
Suriname import shipments of recombinant hormones in 2024 continued to be primarily sourced from the United States of America, Netherlands, Brazil, United Kingdom, and India. The high Herfindahl-Hirschman Index (HHI) indicates a concentrated market, while the significant negative Compound Annual Growth Rate (CAGR) from 2020 to 2024 reflects a challenging period for the industry. The sharp decline in growth rate from 2023 to 2024 further underscores the need for market players to reassess strategies and adapt to evolving market dynamics in Suriname.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Suriname Recombinant Hormone Market Overview |
3.1 Suriname Country Macro Economic Indicators |
3.2 Suriname Recombinant Hormone Market Revenues & Volume, 2021 & 2031F |
3.3 Suriname Recombinant Hormone Market - Industry Life Cycle |
3.4 Suriname Recombinant Hormone Market - Porter's Five Forces |
3.5 Suriname Recombinant Hormone Market Revenues & Volume Share, By Hormone Type, 2021 & 2031F |
3.6 Suriname Recombinant Hormone Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Suriname Recombinant Hormone Market Revenues & Volume Share, By End-Use, 2021 & 2031F |
4 Suriname Recombinant Hormone Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of hormone-related disorders in Suriname |
4.2.2 Growing awareness and acceptance of recombinant hormone therapy |
4.2.3 Technological advancements in the field of biotechnology and genetic engineering |
4.3 Market Restraints |
4.3.1 High cost associated with recombinant hormone therapy |
4.3.2 Limited access to advanced healthcare facilities in certain regions of Suriname |
4.3.3 Stringent regulatory requirements for approval and commercialization of recombinant hormone products |
5 Suriname Recombinant Hormone Market Trends |
6 Suriname Recombinant Hormone Market, By Types |
6.1 Suriname Recombinant Hormone Market, By Hormone Type |
6.1.1 Overview and Analysis |
6.1.2 Suriname Recombinant Hormone Market Revenues & Volume, By Hormone Type, 2021 - 2031F |
6.1.3 Suriname Recombinant Hormone Market Revenues & Volume, By Insulin, 2021 - 2031F |
6.1.4 Suriname Recombinant Hormone Market Revenues & Volume, By Growth Hormone, 2021 - 2031F |
6.1.5 Suriname Recombinant Hormone Market Revenues & Volume, By Erythropoietin, 2021 - 2031F |
6.2 Suriname Recombinant Hormone Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Suriname Recombinant Hormone Market Revenues & Volume, By Diabetes Management, 2021 - 2031F |
6.2.3 Suriname Recombinant Hormone Market Revenues & Volume, By Growth Disorders, 2021 - 2031F |
6.2.4 Suriname Recombinant Hormone Market Revenues & Volume, By Anemia Treatment, 2021 - 2031F |
6.3 Suriname Recombinant Hormone Market, By End-Use |
6.3.1 Overview and Analysis |
6.3.2 Suriname Recombinant Hormone Market Revenues & Volume, By Healthcare, 2021 - 2031F |
6.3.3 Suriname Recombinant Hormone Market Revenues & Volume, By Pharmaceuticals, 2021 - 2031F |
6.3.4 Suriname Recombinant Hormone Market Revenues & Volume, By Biotechnology, 2021 - 2031F |
7 Suriname Recombinant Hormone Market Import-Export Trade Statistics |
7.1 Suriname Recombinant Hormone Market Export to Major Countries |
7.2 Suriname Recombinant Hormone Market Imports from Major Countries |
8 Suriname Recombinant Hormone Market Key Performance Indicators |
8.1 Patient adherence rate to recombinant hormone therapy |
8.2 Number of healthcare providers offering recombinant hormone treatments |
8.3 Rate of adoption of recombinant hormone therapy in Suriname |
9 Suriname Recombinant Hormone Market - Opportunity Assessment |
9.1 Suriname Recombinant Hormone Market Opportunity Assessment, By Hormone Type, 2021 & 2031F |
9.2 Suriname Recombinant Hormone Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Suriname Recombinant Hormone Market Opportunity Assessment, By End-Use, 2021 & 2031F |
10 Suriname Recombinant Hormone Market - Competitive Landscape |
10.1 Suriname Recombinant Hormone Market Revenue Share, By Companies, 2024 |
10.2 Suriname Recombinant Hormone Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here